TNFRSF14 and breast carcinoma: In previous experiments, for the two human breast cancer cell lines, we found that RT not only increased the expression of PD-L1 on the tumor cell surface, but also of PD-L2 and HVEM and other immune checkpoint stimulatory inhibitors in a time- and cell line-dependent manner [14].